Onglyza is a class of drugs known as “incretin mimetics” which are drugs approved for the treatment of type-2 diabetes. In recent years our firm has been involved in lawsuits across the United States involving various diabetes drugs and treatments, such as Actos, Granuflo, Januvia, and Janumet.
Another diabetes drug, Onglyza, should have patients worried as well, as it appears that AstraZeneca and Bristol-Myers Squibb withheld important information about the risk of severe and life threatening medical conditions caused by taking Onglyza. There is now solid medical evidence establishing an increased risk of heart failure and heart attack for users of Onglyza.
Some of the most severe health conditions include:
- Heart failure
- Heart attack
- Increased risk of pancreatitis
- Pancreatic cancer
If you or a loved one has suffered serious health problems as a result of taking Onglyza, please fill out the form below or contact the Holland Law Firm immediately for a free consultation to protect your rights to the compensation you deserve.